Get the Stockscreener App
1.025
4.21%
-0.045
After Hours:
1.01
-0.015
-1.46%
Bone Biologics Corp stock is traded at $1.025, with a volume of 80,551.
It is down -4.21% in the last 24 hours and down -26.79% over the past month.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
See More
Previous Close:
$1.07
Open:
$1.08
24h Volume:
80,551
Relative Volume:
1.42
Market Cap:
$1.84M
Revenue:
-
Net Income/Loss:
$-2.86M
P/E Ratio:
-0.4088
EPS:
-2.5071
Net Cash Flow:
$-2.57M
1W Performance:
-8.48%
1M Performance:
-26.79%
6M Performance:
-38.62%
1Y Performance:
-66.06%
1-Day Range:
$1.01
$1.09
1-Week Range:
$1.01
$1.15
52-Week Range:
$1.01
$4.1299
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.025 | 1.92M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Bone Biologics Corp Stock (BBLG) Latest News
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - TradingView
TradingKey - TradingKey
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Bone Biologics (Nasdaq: BBLG) raises $3M, extends runway to 2027 - Stock Titan
Bone Biologics extends rhNELL-1 shelf life to 29 months - Stock Titan
Price to book forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Form S-3 Bone Biologics Corp For: 17 July - Investing.com India
Form S-3 Bone Biologics Corp For: 17 July By Investing.com - Investing.com Nigeria
Bone Biologics (NASDAQ: BBLG) registers 6.46M warrant shares for resale - Stock Titan
Bone postpones 2026 annual meeting to Sept. 28, sets new record date Aug. 6 - TradingView
Bone Biologics (NASDAQ: BBLG) delays 2026 meeting to September 28 - Stock Titan
World Fiber Viable Bone MatrixMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Enterprise value to revenue forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Surprises; Stock Holds SteadyROE Trend Analysis - dars.gov.et
Price to sales forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to EBIT forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Enterprise value to revenue forward of Bone Biologics Corp – BOATS:BBLGW - TradingView
Orthobiologics Devices And Equipment Market Report 2026 Market Outlook Supported By A Forecast 8% CAGR - openPR.com
Bone Biologics Announces $9 Million Private Placement for Spine Fusion Innovation and Clinical Trials Funding 12 - Minichart
Bone Biologics Raises $2.7 Million in Private Placement; Adds $6 Million Upside From Warrants - TradingView
Bone Biologics (BBLG) raises $3M in private placement with up to $6M via warrants - Stock Titan
Bone Biologics Corp (BBLG) Edges Higher Amid Low Volume, Tests Key Resistance LevelsMonthly Profile - dars.gov.et
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Biotech Stock DeclinesGuidance vs Actual - Bölüm Sonu Canavarı
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket - Benzinga
What Put Bone Biologics (NASDAQ:BBLG) on Nasdaq Composite Radar? - Kalkine Media
Bone Biologics raises $3M now, with up to $6M more from warrants - Stock Titan
Bone Biologics Announces $3 Million Private Placement Financing with Potential Additional $6 Million from Warrants - Quiver Quantitative
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Demineralized Bone Matrix Market Report 2026 Market Outlook Supported By A Forecast 6.3% CAGR - openPR.com
AMAT Q2 2026 Earnings: EPS Surpasses Estimates But Stock Declines Over 7%Full Year Guidance - dars.gov.et
Executive pay and board elections at Bone Biologics (NASDAQ: BBLG) - Stock Titan
Bone Biologics Corp SEC Filing (Jul 2, 2026) - Stock Titan
CISS Q3 2025 Earnings: Net Loss of $0.58 Per Share; Stock Trades at $0.61Full Year Guidance - dars.gov.et
ADRMD Stock Price and Chart — OTC:ADRMD - TradingView
Bone Biologics Corp (BBLG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLGW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Bone Biologics Corp Warrants (BBLGW) Slide as Selling Pressure Intensifies Near Support LevelsReversal Setup Alerts - dars.gov.et
Bone Biologics Corp (BBLG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLG) Institutional Confidence - TradingKey
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):